Matrix Metalloproteinases Neutralizing Agents in Oral Lichen Planus

• Status: Active, not recruiting
• Trial end date: 2020-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The current study will be conducted to evaluate the effectiveness of matrix metalloproteinases inhibitors on erosive oral lichen planus.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Jaylane kadry Ghonima
• Treatments: Matrix Metalloproteinase Inhibitors; Triamcinolone Acetonide

Criteria

Inclusion Criteria:

• patients diagnosed with erosive OLP confirmed with a biopsy.

• patients should have symptomatic lesions

Exclusion Criteria:

• Patients who were under anticoagulant medications, suffering from any systemic diseases or having any physical or mental abnormality, pregnant and lactating women, smokers.